{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T12:05:51Z","timestamp":1770984351605,"version":"3.50.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T00:00:00Z","timestamp":1581638400000},"content-version":"vor","delay-in-days":13,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["WA 1552\/8-1"],"award-info":[{"award-number":["WA 1552\/8-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["HE 2509\/14-1"],"award-info":[{"award-number":["HE 2509\/14-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2020,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Drug-induced liver injury (DILI) represents one of the major causes why drugs have to be withdrawn from the market. In this study, we describe a new interaction between drug-exposed hepatocytes and natural killer (NK) cells. In a previous genome-wide expression analysis of primary human hepatocytes that had been exposed to clinically relevant concentrations of 148 drugs, we found that several activating ligands for NK cell receptors were regulated by various drugs (e.g., valproic acid, ketoconazole, promethazine, isoniazid). Especially expression of the activating NKG2D ligands (MICA, MICB and ULBPs) and the NKp30 ligand B7-H6 were upregulated in primary human hepatocytes upon exposure to many different drugs. Using the human hepatocyte cell lines Huh7 and HepG2, we confirmed that protein levels of activating NK cell ligands were elevated after drug exposure. Hepatocyte cell lines or primary human hepatocytes co-cultivated with NK cells caused enhanced NK cell activation after pretreatment with drugs at in vivo relevant concentrations compared to solvent controls. Enhanced NK cell activation was evident by increased cytotoxicity against hepatocytes and interferon (IFN)-\u03b3 production. NK cell activation could be blocked by specific antibodies against activating NK cell receptors. These data support the hypothesis that NK cells can modulate drug-induced liver injury by direct interaction with hepatocytes resulting in cytotoxicity and IFN-\u03b3 production.<\/jats:p>","DOI":"10.1007\/s00204-020-02668-8","type":"journal-article","created":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T15:04:47Z","timestamp":1581692687000},"page":"439-448","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Enhanced activation of human NK cells by drug-exposed hepatocytes"],"prefix":"10.1007","volume":"94","author":[{"given":"Frank","family":"Fasbender","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Obholzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Metzler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Regina","family":"St\u00f6ber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan G.","family":"Hengstler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5195-0995","authenticated-orcid":false,"given":"Carsten","family":"Watzl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,2,14]]},"reference":[{"issue":"2","key":"2668_CR1","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/toxsci\/kfq009","volume":"115","author":"DH Adams","year":"2010","unstructured":"Adams DH, Ju C, Ramaiah SK, Uetrecht J, Jaeschke H (2010) Mechanisms of immune-mediated liver injury. Toxicol Sci 115(2):307\u2013321. https:\/\/doi.org\/10.1093\/toxsci\/kfq009","journal-title":"Toxicol Sci"},{"issue":"10","key":"2668_CR2","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1002\/eji.201970107","volume":"49","author":"HDC Andrea Cossarizza","year":"2019","unstructured":"Andrea Cossarizza HDC, Radbruch A, Acs A, Adam D, Adam-Klages S, Agace WW, Aghaeepour N, Akdis M, Allez M, Almeida LN, Alvisi G, Anderson G, Andr\u00e4 I, Annunziato F, Anselmo A, Bacher P, Baldari CT, Bari S, Barnaba V, Barros-Martins J, Battistini L, Bauer W, Baumgart S, Baumgarth N, Baumjohann D, Baying B, Bebawy M, Becher B, Beisker W, Benes V, Beyaert R, Blanco A, Boardman DA, Bogdan C, Borger JG, Borsellino G, Boulais PE, Bradford JA, Brenner D, Brinkman RR, Brooks AES, Busch DH, B\u00fcscher M, Bushnell TP, Calzetti F, Cameron G, Cammarata I, Cao X, Cardell SL, Casola S, Cassatella MA, Cavani A, Celada A, Chatenoud L, Chattopadhyay PK, Chow S, Christakou E, \u010ci\u010din-\u0160ain L, Clerici M, Colombo FS, Cook L, Cooke A, Cooper AM, Corbett AJ, Cosma A, Cosmi L, Coulie PG, Cumano A, Cvetkovic L, Dang VD, Dang-Heine C, Davey MS, Davies D, De Biasi S, Del Zotto G, Cruz GVD, Delacher M, Bella SD, Dellabona P, Deniz G, Dessing M, Di Santo JP, Diefenbach A, Dieli F, Dolf A, D\u00f6rner T, Dress RJ, Dudziak D, Dustin M, Dutertre C-A, Ebner F, Eckle SBG, Edinger M, Eede P, Ehrhardt GRA, Eich M, Engel P, Engelhardt B, Erdei A, Esser C, Everts B, Evrard M, Falk CS, Fehniger TA, Felipo-Benavent M, Ferry H, Feuerer M, Filby A, Filkor K, Fillatreau S, Follo M, F\u00f6rster I, Foster J, Foulds GA, Frehse B, Frenette PS, Frischbutter S, Fritzsche W, Galbraith DW, Gangaev A, Garbi N, Gaudilliere B, Gazzinelli RT, Geginat J, Gerner W, Gherardin NA, Ghoreschi K, Gibellini L, Ginhoux F, Goda K, Godfrey DI, Goettlinger C, Gonz\u00e1lez-Navajas JM, Goodyear CS, Gori A, Grogan JL, Grummitt D, Gr\u00fctzkau A, Haftmann C, Hahn J, Hammad H, H\u00e4mmerling G, Hansmann L, Hansson G, Harpur CM, Hartmann S, Hauser A, Hauser AE, Haviland DL (2019) Guidelines for the use of flow cytometry and cell sorting in immunological studies. Eur J Immunol 49(10):1457\u20131973","journal-title":"Eur J Immunol"},{"issue":"14","key":"2668_CR3","doi-asserted-by":"publisher","first-page":"6321","DOI":"10.1158\/0008-5472.CAN-04-4252","volume":"65","author":"S Armeanu","year":"2005","unstructured":"Armeanu S, Bitzer M, Lauer UM et al (2005) Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate. Cancer Res 65(14):6321\u20136329. https:\/\/doi.org\/10.1158\/0008-5472.CAN-04-4252","journal-title":"Cancer Res"},{"issue":"6","key":"2668_CR5","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1177\/1087057111402825","volume":"16","author":"FA Atienzar","year":"2011","unstructured":"Atienzar FA, Tilmant K, Gerets HH et al (2011) The use of real-time cell analyzer technology in drug discovery: defining optimal cell culture conditions and assay reproducibility with different adherent cellular models. J Biomol Screen 16(6):575\u2013587. https:\/\/doi.org\/10.1177\/1087057111402825","journal-title":"J Biomol Screen"},{"issue":"1","key":"2668_CR4","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3390\/bios3010132","volume":"3","author":"FA Atienzar","year":"2013","unstructured":"Atienzar FA, Gerets H, Tilmant K, Toussaint G, Dhalluin S (2013) Evaluation of impedance-based label-free technology as a tool for pharmacology and toxicology investigations. Biosensors (Basel) 3(1):132\u2013156. https:\/\/doi.org\/10.3390\/bios3010132","journal-title":"Biosensors (Basel)"},{"issue":"6","key":"2668_CR6","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1080\/15321819.2016.1179646","volume":"37","author":"AM Attallah","year":"2016","unstructured":"Attallah AM, El-Far M, Zahran F et al (2016) Interferon-gamma is associated with hepatic dysfunction in fibrosis, cirrhosis, and hepatocellular carcinoma. J Immunoassay Immunochem 37(6):597\u2013610. https:\/\/doi.org\/10.1080\/15321819.2016.1179646","journal-title":"J Immunoassay Immunochem"},{"issue":"2","key":"2668_CR7","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.4049\/jimmunol.173.2.1078","volume":"173","author":"L Bacon","year":"2004","unstructured":"Bacon L, Eagle RA, Meyer M, Easom N, Young NT, Trowsdale J (2004) Two human ULBP\/RAET1 molecules with transmembrane regions are ligands for NKG2D. J Immunol 173(2):1078\u20131084","journal-title":"J Immunol"},{"issue":"5","key":"2668_CR8","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.coi.2005.07.016","volume":"17","author":"S Bahram","year":"2005","unstructured":"Bahram S, Inoko H, Shiina T, Radosavljevic M (2005) MIC and other NKG2D ligands: from none to too many. Curr Opin Immunol 17(5):505\u2013509. https:\/\/doi.org\/10.1016\/j.coi.2005.07.016","journal-title":"Curr Opin Immunol"},{"issue":"7","key":"2668_CR9","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1084\/jem.20090681","volume":"206","author":"CS Brandt","year":"2009","unstructured":"Brandt CS, Baratin M, Yi EC et al (2009) The B7 family member B7\u2013H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans. J Exp Med 206(7):1495\u20131503. https:\/\/doi.org\/10.1084\/jem.20090681","journal-title":"J Exp Med"},{"issue":"12","key":"2668_CR10","doi-asserted-by":"publisher","first-page":"e1339","DOI":"10.1371\/journal.pone.0001339","volume":"2","author":"A Byrd","year":"2007","unstructured":"Byrd A, Hoffmann SC, Jarahian M, Momburg F, Watzl C (2007) Expression analysis of the ligands for the natural killer cell receptors NKp30 and NKp44. PLoS ONE ONE 2(12):e1339. https:\/\/doi.org\/10.1371\/journal.pone.0001339","journal-title":"PLoS ONE ONE"},{"issue":"1","key":"2668_CR11","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0006-291X(03)00714-9","volume":"305","author":"NJ Chalupny","year":"2003","unstructured":"Chalupny NJ, Sutherland CL, Lawrence WA, Rein-Weston A, Cosman D (2003) ULBP4 is a novel ligand for human NKG2D. Biochem Biophys Res Commun 305(1):129\u2013135","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"2668_CR12","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S1074-7613(01)00095-4","volume":"14","author":"D Cosman","year":"2001","unstructured":"Cosman D, M\u00fcllberg J, Sutherland CL et al (2001) ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 14(2):123\u2013133","journal-title":"Immunity"},{"issue":"6230","key":"2668_CR13","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1126\/science.1258867","volume":"348","author":"W Deng","year":"2015","unstructured":"Deng W, Gowen BG, Zhang L et al (2015) Antitumor immunity. A shed NKG2D ligand that promotes natural killer cell activation and tumor rejection. Science 348(6230):136\u2013139. https:\/\/doi.org\/10.1126\/science.1258867","journal-title":"Science"},{"key":"2668_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-23368-5","author":"F Fasbender","year":"2018","unstructured":"Fasbender F, Watzl C (2018) Impedance-based analysis of natural killer cell stimulation. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-018-23368-5","journal-title":"Sci Rep"},{"key":"2668_CR15","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3389\/fimmu.2016.00019","volume":"7","author":"F Fasbender","year":"2016","unstructured":"Fasbender F, Widera A, Hengstler JG, Watzl C (2016) Natural killer cells and liver fibrosis. Front Immunol 7:19. https:\/\/doi.org\/10.3389\/fimmu.2016.00019","journal-title":"Front Immunol"},{"issue":"1","key":"2668_CR16","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1586\/17474124.1.1.173","volume":"1","author":"B Gao","year":"2007","unstructured":"Gao B, Radaeva S, Jeong WI (2007) Activation of natural killer cells inhibits liver fibrosis: a novel strategy to treat liver fibrosis. Expert Rev Gastroenterol Hepatol 1(1):173\u2013180. https:\/\/doi.org\/10.1586\/17474124.1.1.173","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"3\u20134","key":"2668_CR17","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/0162-3109(84)90033-x","volume":"7","author":"P Gergely","year":"1984","unstructured":"Gergely P, Nekam K, Lang I, Kalmar L, Gonzalez-Cabello R, Perl A (1984) Ketoconazole in vitro inhibits mitogen-induced blastogenesis, antibody-dependent cellular cytotoxicity, natural killer activity and random migration of human leukocytes. Immunopharmacology 7(3\u20134):167\u2013170. https:\/\/doi.org\/10.1016\/0162-3109(84)90033-x","journal-title":"Immunopharmacology"},{"issue":"8","key":"2668_CR18","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1007\/s00204-013-1078-5","volume":"87","author":"P Godoy","year":"2013","unstructured":"Godoy P, Hewitt NJ, Albrecht U et al (2013) Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Arch Toxicol 87(8):1315\u20131530. https:\/\/doi.org\/10.1007\/s00204-013-1078-5","journal-title":"Arch Toxicol"},{"issue":"12","key":"2668_CR19","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1007\/s00204-014-1400-x","volume":"88","author":"M Grinberg","year":"2014","unstructured":"Grinberg M, Stober RM, Edlund K et al (2014) Toxicogenomics directory of chemically exposed human hepatocytes. Arch Toxicol 88(12):2261\u20132287. https:\/\/doi.org\/10.1007\/s00204-014-1400-x","journal-title":"Arch Toxicol"},{"issue":"6","key":"2668_CR20","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1136\/gutjnl-2011-301400","volume":"61","author":"C Gur","year":"2012","unstructured":"Gur C, Doron S, Kfir-Erenfeld S et al (2012) NKp46-mediated killing of human and mouse hepatic stellate cells attenuates liver fibrosis. Gut 61(6):885\u2013893. https:\/\/doi.org\/10.1136\/gutjnl-2011-301400","journal-title":"Gut"},{"issue":"1","key":"2668_CR21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cytogfr.2011.01.001","volume":"22","author":"CJ Horras","year":"2011","unstructured":"Horras CJ, Lamb CL, Mitchell KA (2011) Regulation of hepatocyte fate by interferon-gamma. Cytokine Growth Factor Rev 22(1):35\u201343. https:\/\/doi.org\/10.1016\/j.cytogfr.2011.01.001","journal-title":"Cytokine Growth Factor Rev"},{"issue":"2","key":"2668_CR22","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3390\/bios5020199","volume":"5","author":"D Kho","year":"2015","unstructured":"Kho D, MacDonald C, Johnson R et al (2015) Application of xCELLigence RTCA biosensor technology for revealing the profile and window of drug responsiveness in real time. Biosensors (Basel) 5(2):199\u2013222. https:\/\/doi.org\/10.3390\/bios5020199","journal-title":"Biosensors (Basel)"},{"issue":"4","key":"2668_CR23","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1002\/hep.25804","volume":"56","author":"B Kramer","year":"2012","unstructured":"Kramer B, Korner C, Kebschull M et al (2012) Natural killer p46High expression defines a natural killer cell subset that is potentially involved in control of hepatitis C virus replication and modulation of liver fibrosis. Hepatology 56(4):1201\u20131213. https:\/\/doi.org\/10.1002\/hep.25804","journal-title":"Hepatology"},{"issue":"2","key":"2668_CR24","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.jhep.2014.08.038","volume":"62","author":"B Langhans","year":"2015","unstructured":"Langhans B, Alwan AW, Kramer B et al (2015) Regulatory CD4(+) T cells modulate the interaction between NK cells and hepatic stellate cells by acting on either cell type. J Hepatol 62(2):398\u2013404. https:\/\/doi.org\/10.1016\/j.jhep.2014.08.038","journal-title":"J Hepatol"},{"issue":"6","key":"2668_CR25","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1002\/hep.20948","volume":"42","author":"AM Larson","year":"2005","unstructured":"Larson AM, Polson J, Fontana RJ et al (2005) Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology 42(6):1364\u20131372. https:\/\/doi.org\/10.1002\/hep.20948","journal-title":"Hepatology"},{"issue":"3","key":"2668_CR26","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1097\/01.mog.0000218958.40441.fd","volume":"22","author":"JH Lewis","year":"2006","unstructured":"Lewis JH, Ahmed M, Shobassy A, Palese C (2006) Drug-induced liver disease. Curr Opin Gastroenterol 22(3):223\u2013233. https:\/\/doi.org\/10.1097\/01.mog.0000218958.40441.fd","journal-title":"Curr Opin Gastroenterol"},{"issue":"12","key":"2668_CR27","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1021\/acs.chemrestox.5b00305","volume":"28","author":"A Mak","year":"2015","unstructured":"Mak A, Uetrecht J (2015) The combination of anti-CTLA-4 and PD1-\/- mice unmasks the potential of isoniazid and nevirapine to cause liver injury. Chem Res Toxicol 28(12):2287\u20132291. https:\/\/doi.org\/10.1021\/acs.chemrestox.5b00305","journal-title":"Chem Res Toxicol"},{"issue":"1","key":"2668_CR28","first-page":"145","volume":"3","author":"A Mak","year":"2017","unstructured":"Mak A, Uetrecht J (2017) Immune mechanisms of idiosyncratic drug-induced liver injury. J Clin Transl Res 3(1):145\u2013156","journal-title":"J Clin Transl Res"},{"issue":"2","key":"2668_CR29","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/imm.12495","volume":"146","author":"S Mantovani","year":"2015","unstructured":"Mantovani S, Mele D, Oliviero B, Barbarini G, Varchetta S, Mondelli MU (2015) NKp30 isoforms in patients with chronic hepatitis C virus infection. Immunology 146(2):234\u2013242. https:\/\/doi.org\/10.1111\/imm.12495","journal-title":"Immunology"},{"issue":"2","key":"2668_CR30","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.immuni.2013.07.018","volume":"39","author":"T McHedlidze","year":"2013","unstructured":"McHedlidze T, Waldner M, Zopf S et al (2013) Interleukin-33-dependent innate lymphoid cells mediate hepatic fibrosis. Immunity 39(2):357\u2013371. https:\/\/doi.org\/10.1016\/j.immuni.2013.07.018","journal-title":"Immunity"},{"issue":"1","key":"2668_CR31","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jhep.2005.12.025","volume":"45","author":"A Melhem","year":"2006","unstructured":"Melhem A, Muhanna N, Bishara A et al (2006) Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSC. J Hepatol 45(1):60\u201371. https:\/\/doi.org\/10.1016\/j.jhep.2005.12.025","journal-title":"J Hepatol"},{"issue":"5","key":"2668_CR32","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.4049\/jimmunol.172.5.2731","volume":"172","author":"J Mestas","year":"2004","unstructured":"Mestas J, Hughes CCW (2004) Of mice and not men: Differences between mouse and human immunology. J Immunol 172(5):2731\u20132738. https:\/\/doi.org\/10.4049\/jimmunol.172.5.2731","journal-title":"J Immunol"},{"issue":"2","key":"2668_CR33","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jneumeth.2011.07.005","volume":"200","author":"K Moodley","year":"2011","unstructured":"Moodley K, Angel CE, Glass M, Graham ES (2011) Real-time profiling of NK cell killing of human astrocytes using xCELLigence technology. J Neurosci Meth 200(2):173\u2013180. https:\/\/doi.org\/10.1016\/j.jneumeth.2011.07.005","journal-title":"J Neurosci Meth"},{"issue":"1","key":"2668_CR34","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1136\/gut.2010.211136","volume":"60","author":"N Muhanna","year":"2011","unstructured":"Muhanna N, Abu Tair L, Doron S et al (2011) Amelioration of hepatic fibrosis by NK cell activation. Gut 60(1):90\u201398. https:\/\/doi.org\/10.1136\/gut.2010.211136","journal-title":"Gut"},{"issue":"5","key":"2668_CR35","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1002\/hep.20204","volume":"39","author":"M Ochi","year":"2004","unstructured":"Ochi M, Ohdan H, Mitsuta H et al (2004) Liver NK cells expressing TRAIL are toxic against self hepatocytes in mice. Hepatology 39(5):1321\u20131331. https:\/\/doi.org\/10.1002\/hep.20204","journal-title":"Hepatology"},{"issue":"7","key":"2668_CR36","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.febslet.2007.02.045","volume":"581","author":"H Ogbomo","year":"2007","unstructured":"Ogbomo H, Michaelis M, Kreuter J, Doerr HW, Cinatl J Jr (2007) Histone deacetylase inhibitors suppress natural killer cell cytolytic activity. FEBS Lett 581(7):1317\u20131322. https:\/\/doi.org\/10.1016\/j.febslet.2007.02.045","journal-title":"FEBS Lett"},{"issue":"12","key":"2668_CR37","doi-asserted-by":"publisher","first-page":"947","DOI":"10.7326\/0003-4819-137-12-200212170-00007","volume":"137","author":"G Ostapowicz","year":"2002","unstructured":"Ostapowicz G, Fontana RJ, Schiodt FV et al (2002) Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 137(12):947\u2013954","journal-title":"Ann Intern Med"},{"issue":"12","key":"2668_CR38","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1038\/ni.1953","volume":"11","author":"S Paust","year":"2010","unstructured":"Paust S, Gill HS, Wang B-Z et al (2010) Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses. Nat Immunol 11(12):1127\u20131135. https:\/\/doi.org\/10.1038\/ni.1953","journal-title":"Nat Immunol"},{"issue":"5","key":"2668_CR39","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.it.2015.03.006","volume":"36","author":"H Peng","year":"2015","unstructured":"Peng H, Tian Z (2015) Re-examining the origin and function of liver-resident NK cells. Trends Immunol 36(5):293\u2013299. https:\/\/doi.org\/10.1016\/j.it.2015.03.006","journal-title":"Trends Immunol"},{"key":"2668_CR40","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.jim.2014.01.012","volume":"405","author":"JK Peper","year":"2014","unstructured":"Peper JK, Schuster H, Loffler MW, Schmid-Horch B, Rammensee HG, Stevanovic S (2014) An impedance-based cytotoxicity assay for real-time and label-free assessment of T-cell-mediated killing of adherent cells. J Immunol Methods 405:192\u2013198. https:\/\/doi.org\/10.1016\/j.jim.2014.01.012","journal-title":"J Immunol Methods"},{"issue":"6","key":"2668_CR41","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.immuni.2007.10.010","volume":"27","author":"E Pogge von Strandmann","year":"2007","unstructured":"Pogge von Strandmann E, Simhadri VR, von Tresckow B et al (2007) Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer cells. Immunity 27(6):965\u2013974. https:\/\/doi.org\/10.1016\/j.immuni.2007.10.010","journal-title":"Immunity"},{"issue":"9","key":"2668_CR42","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1084\/jem.20181454","volume":"216","author":"I Prager","year":"2019","unstructured":"Prager I, Liesche C, van Ooijen H et al (2019) NK cells switch from granzyme B to death receptor-mediated cytotoxicity during serial killing. J Exp Med 216(9):2113\u20132127. https:\/\/doi.org\/10.1084\/jem.20181454","journal-title":"J Exp Med"},{"issue":"2","key":"2668_CR43","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1053\/j.gastro.2005.10.055","volume":"130","author":"S Radaeva","year":"2006","unstructured":"Radaeva S, Sun R, Jaruga B, Nguyen VT, Tian Z, Gao B (2006) Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners. Gastroenterology 130(2):435\u2013452. https:\/\/doi.org\/10.1053\/j.gastro.2005.10.055","journal-title":"Gastroenterology"},{"issue":"4","key":"2668_CR44","doi-asserted-by":"publisher","first-page":"G809","DOI":"10.1152\/ajpgi.00212.2007","volume":"293","author":"S Radaeva","year":"2007","unstructured":"Radaeva S, Wang L, Radaev S, Jeong WI, Park O, Gao B (2007) Retinoic acid signaling sensitizes hepatic stellate cells to NK cell killing via upregulation of NK cell activating ligand RAE1. Am J Physiol Gastrointest Liver Physiol 293(4):G809\u2013G816. https:\/\/doi.org\/10.1152\/ajpgi.00212.2007","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2668_CR45","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1146\/annurev-immunol-032712-095951","volume":"31","author":"DH Raulet","year":"2013","unstructured":"Raulet DH, Gasser S, Gowen BG, Deng W, Jung H (2013) Regulation of ligands for the NKG2D activating receptor. Annu Rev Immunol 31:413\u2013441. https:\/\/doi.org\/10.1146\/annurev-immunol-032712-095951","journal-title":"Annu Rev Immunol"},{"issue":"3","key":"2668_CR46","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/0162-3109(95)00029-S","volume":"30","author":"P Ravn","year":"1995","unstructured":"Ravn P, Linnet J, Klokker M, Pedersen BK (1995) Effects of isoniazid treatment on human lymphocyte proliferative response, lymphocyte subsets and natural-killer-cell activity. Immunopharmacology 30(3):247\u2013253. https:\/\/doi.org\/10.1016\/0162-3109(95)00029-S","journal-title":"Immunopharmacology"},{"issue":"4","key":"2668_CR47","first-page":"660","volume":"42","author":"DC Rockey","year":"1994","unstructured":"Rockey DC, Chung JJ (1994) Interferon gamma inhibits lipocyte activation and extracellular matrix mRNA expression during experimental liver injury: implications for treatment of hepatic fibrosis. J Investig Med 42(4):660\u2013670","journal-title":"J Investig Med"},{"issue":"2","key":"2668_CR48","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/0162-3109(88)90058-6","volume":"15","author":"G Rychlik","year":"1988","unstructured":"Rychlik G, Rychlik E, Wasik M (1988) Influence of promethazine on immune-reactions. 1. Characterization of promethazine effects on natural-killer cell-mediated cyto-toxicity. Immunopharmacology 15(2):117\u2013122. https:\/\/doi.org\/10.1016\/0162-3109(88)90058-6","journal-title":"Immunopharmacology"},{"issue":"13","key":"2668_CR49","doi-asserted-by":"publisher","first-page":"3429","DOI":"10.1158\/0008-5472.CAN-13-3017","volume":"74","author":"E Schlecker","year":"2014","unstructured":"Schlecker E, Fiegler N, Arnold A et al (2014) Metalloprotease-mediated tumor cell shedding of B7\u2013H6, the ligand of the natural killer cell-activating receptor NKp30. Cancer Res 74(13):3429\u20133440. https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-3017","journal-title":"Cancer Res"},{"issue":"3","key":"2668_CR50","first-page":"600","volume":"6","author":"X Shi","year":"2016","unstructured":"Shi X, Li M, Cui M et al (2016) Epigenetic suppression of the antitumor cytotoxicity of NK cells by histone deacetylase inhibitor valproic acid. Am J Cancer Res 6(3):600\u2013614","journal-title":"Am J Cancer Res"},{"issue":"5","key":"2668_CR51","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1053\/j.gastro.2004.08.055","volume":"127","author":"R Sun","year":"2004","unstructured":"Sun R, Gao B (2004) Negative regulation of liver regeneration by innate immunity (natural killer cells\/interferon-gamma). Gastroenterology 127(5):1525\u20131539. https:\/\/doi.org\/10.1053\/j.gastro.2004.08.055","journal-title":"Gastroenterology"},{"issue":"5","key":"2668_CR52","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1002\/hep.21378","volume":"44","author":"A Warren","year":"2006","unstructured":"Warren A, Le Couteur DG, Fraser R, Bowen DG, McCaughan GW, Bertolino P (2006) T lymphocytes interact with hepatocytes through fenestrations in murine liver sinusoidal endothelial cells. Hepatology 44(5):1182\u20131190. https:\/\/doi.org\/10.1002\/hep.21378","journal-title":"Hepatology"},{"key":"2668_CR53","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/B978-0-12-800147-9.00005-4","volume":"124","author":"C Watzl","year":"2014","unstructured":"Watzl C (2014) How to trigger a killer: modulation of natural killer cell reactivity on many levels. Adv Immunol 124:137\u2013170. https:\/\/doi.org\/10.1016\/B978-0-12-800147-9.00005-4","journal-title":"Adv Immunol"},{"key":"2668_CR54","doi-asserted-by":"publisher","first-page":"87","DOI":"10.12703\/P6-87","volume":"6","author":"C Watzl","year":"2014","unstructured":"Watzl C, Urlaub D, Fasbender F, Claus M (2014) Natural killer cell regulation\u2014beyond the receptors. F1000Prime Rep 6:87. https:\/\/doi.org\/10.12703\/P6-87","journal-title":"F1000Prime Rep"},{"issue":"1","key":"2668_CR55","doi-asserted-by":"publisher","first-page":"G275","DOI":"10.1152\/ajpgi.00026.2010","volume":"299","author":"HR Wei","year":"2010","unstructured":"Wei HR, Wei HM, Wang H, Tian ZG, Sun RI (2010) Activation of natural killer cells inhibits liver regeneration in toxin-induced liver injury model in mice via a tumor necrosis factor-alpha-dependent mechanism. Am J Physiol Gastr L 299(1):G275\u2013G282. https:\/\/doi.org\/10.1152\/ajpgi.00026.2010","journal-title":"Am J Physiol Gastr L"},{"issue":"2","key":"2668_CR56","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/cmi.2016.62","volume":"14","author":"R Weiskirchen","year":"2017","unstructured":"Weiskirchen R, Tacke F (2017) Interleukin-33 in the pathogenesis of liver fibrosis: alarming ILC2 and hepatic stellate cells. Cell Mol Immunol 14(2):143\u2013145. https:\/\/doi.org\/10.1038\/cmi.2016.62","journal-title":"Cell Mol Immunol"},{"issue":"2","key":"2668_CR57","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.jhep.2019.03.012","volume":"71","author":"RS Wijaya","year":"2019","unstructured":"Wijaya RS, Read SA, Schibeci S et al (2019) KLRG1+ natural killer cells exert a novel antifibrotic function in chronic hepatitis B. J Hepatol 71(2):252\u2013264. https:\/\/doi.org\/10.1016\/j.jhep.2019.03.012","journal-title":"J Hepatol"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-020-02668-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00204-020-02668-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-020-02668-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,13]],"date-time":"2021-02-13T20:57:42Z","timestamp":1613249862000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00204-020-02668-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["2668"],"URL":"https:\/\/doi.org\/10.1007\/s00204-020-02668-8","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"15 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}